Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Major Milestones: Female Sexual Dysfunction' returned 5 results - Page 1 of 1   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Female Sexual Dysfunction Therapy Area Pipeline Report   Life Science Analytics, March 2011, Pages: 90 Products --Top 5 Companies in Marketed Female Sexual Dysfunction Products Patent Expirations Upcoming Milestones Product Sales Full Pipeline View --Product Details : Unknown/Research --Product Details : Pre The Fastest Growing Biotechnology Companies: Growth Strategies, Comparative Analyses and Company Profiles   Business Insights, March 2008, Pages: 280 development programs 128 Bremelanotide (formerly PT-141) 129 Male sexual dysfunction (MED) 129 Female sexual dysfunction (FSD) 129 Development of novel natriuretic receptor compounds 129 Chapter 6 Pharmion Apricus Bioscience Inc - Product Pipeline Review - H2 2011   Global Markets Direct, Nov 2011, Pages: 129 for late stage and clinical stage products of Apricus Bioscience Inc with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones Repros Therapeutics Inc. - Product Pipeline Review - H2 2011   Global Markets Direct, Nov 2011, Pages: 72 of Female Sexual Dysfunction Sep 07, 2011: Repros Reports Interim Data From Phase III Study Of Low Dose Oral Proellex Sep 07, 2000: Clinical Results from Zonagen's Vasofem Study Show Promise BioSante Pharmaceuticals, Inc. - Product Pipeline Review - H2 2011   Global Markets Direct, Nov 2011, Pages: 115 Dec 28, 2006: BioSante Pharmaceuticals Initiates Phase III Study Of LibiGel (Transdermal Testosterone Gel) In The Treatment Of Female Sexual Dysfunction Oct 26, 2010: BioSante Reports Positive Libi Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network